-transparent.png){kind=logo}
A randomized double blind trial was performed to investigate the effect of the platelet aggregation inhibitor ticlopidine on the rate of decline in renal function in diabetic nephropathy. Twenty-two patients with insulin dependent diabetes complicated by nephropathy completed the trial--11 on ticlopidine, and 11 on placebo for one year. Ticlopidine effectively reduced platelet aggregation in vitro. Renal clearance of 51Cr-EDTA declined from 39 +/- 10 to 30 +/- 13 ml/min per 1.73 m2 body surface in the ticlopidine group and from 42 +/- 9 to 39 +/- 13 in the placebo group. The difference in decline between the two groups was not significant. In the ticlopidine group renal function expressed as the slope coefficient for 1/S-creatinine per month remained the same as before the trial. It is concluded that although there is much evidence to suggest a role of platelets in the development or progression of diabetic nephropathy treatment with ticlopidine could not prevent this process.
G Nyberg, and
O Larsson, and
N G Westberg, and
M Aurell, and
R Jagenburg, and
G Blohmé
July 1992,
Clinical pharmacy,
G Nyberg, and
O Larsson, and
N G Westberg, and
M Aurell, and
R Jagenburg, and
G Blohmé
June 1982,
Angiology,
G Nyberg, and
O Larsson, and
N G Westberg, and
M Aurell, and
R Jagenburg, and
G Blohmé
January 1979,
Archivio "E. Maragliano" di patologia e clinica,
G Nyberg, and
O Larsson, and
N G Westberg, and
M Aurell, and
R Jagenburg, and
G Blohmé
October 1975,
Clinical pharmacology and therapeutics,
G Nyberg, and
O Larsson, and
N G Westberg, and
M Aurell, and
R Jagenburg, and
G Blohmé
June 1978,
Thrombosis research,
G Nyberg, and
O Larsson, and
N G Westberg, and
M Aurell, and
R Jagenburg, and
G Blohmé
January 1995,
Clinical and experimental pharmacology & physiology,
G Nyberg, and
O Larsson, and
N G Westberg, and
M Aurell, and
R Jagenburg, and
G Blohmé
January 2002,
Diabetes care,
G Nyberg, and
O Larsson, and
N G Westberg, and
M Aurell, and
R Jagenburg, and
G Blohmé
May 1993,
Transplantation,
G Nyberg, and
O Larsson, and
N G Westberg, and
M Aurell, and
R Jagenburg, and
G Blohmé
January 2019,
Diabetes & metabolism,
G Nyberg, and
O Larsson, and
N G Westberg, and
M Aurell, and
R Jagenburg, and
G Blohmé
January 1988,
Mayo Clinic proceedings,
